| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-11 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-12 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0001 |